|
|
|
|
Gene Editing Offers Dual Protection Against PRV and PRRSV |
|
|
|
A research team from Northwest A&F University and partners examined the effectiveness of a recombinant Pseudorabies Virus (PRV) in addressing challenges posed by Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and PRV in the pig industry. The findings provide significant insights into the development of vaccines and future prevention and control of NADC30-like PRRSV and PRV.
|
|
|
|
|
Infant is World's First Patient Treated with Customized CRISPR Gene Editing Therapy |
|
|
|
In a historic breakthrough, a child with a rare and life-threatening condition became the first person to receive a customized CRISPR gene editing therapy by a team at the Children's Hospital of Philadelphia (CHOP) and Penn Medicine. The treatment is the first of its kind designed to correct a disease-causing mutation found only in that individual.
|
|
|
|
|
|
|

|
A biweekly update on gene editing research, regulations, and impact
produced by ISAAA Inc. |
| |
|
|

|
| A monthly update on gene drive research and development provided by ISAAA in collaboration with the Outreach Network for Gene Drive Research |
| |
|
|
|
|
|
|